Honoring Linde Klein, changing the course of cancer
David and Dawn Klein’s generosity and vision will forever honor David’s late wife, Linde, who lost her battle with cancer in 2011. The Linde Klein Professorship in Head and Neck Cancer will support a dedicated faculty member who is committed to research and clinical care specific to head and neck cancer at the University’s Wilmot Cancer Institute.
Philanthropy plays a vital role in funding the research needed to combat rare yet devastating cancers like this. At Wilmot, we are committed to a tradition of making discoveries that change the standard of care.
Thank you, David and family, for helping to improve research and care for the people who matter most to us.
Forever grateful
“Thank you, David, Dawn, and the Klein and Yasso families, and all those who contributed to this fund. Linde changed all our lives and made us better people, researchers, and caregivers. I’m proud to have known her. Because of your vision and support, we can continue to research head and neck cancer, care for more patients, and ultimately provide more hope to more people. We are committed to doing this in Linde’s name—forever. We are grateful for your support.”
Mark B. Taubman, MD Professor, Departments of Medicine and Cardiology Dean, School of Medicine & Dentistry CEO, University of Rochester Medical Center
In Linde’s name
“It’s very difficult for one person to know all about every cancer. At Wilmot though, we have specialists who can address all aspects of a particular disease—including a disease like Linde’s that is rare and devastating, and among the most challenging cancers to address. Having the resources to strategically recruit and retain world-class cancer researchers and clinicians is of vital importance. As the region’s leader in cancer treatment, your support helps us continue to offer patients like Linde ongoing access to cutting-edge clinical trials and novel treatments. Your support also helps us make the case for being a National Cancer Institute-designated cancer center. This high honor is based on rigorous standards of research scope, state-of-the-art-education, cancer prevention, and exemplary patient care.”
Jonathan Friedberg, MD, MMSc
Director, Wilmot Cancer Institute
“Linde was an amazing person who fought her cancer with tremendous courage and grace, and she inspired those of us fortunate enough to work with her. The Klein family’s support is very generous and will ultimately benefit underserved cancer patients. Head and neck cancers are relatively rare, and they do not typically receive a lot of traditional research funding. We are incredibly grateful to the Kleins and we will always keep Linde in our fond memories.”
Yuhchyau Chen, MD, PhD
Richard T. Bell Endowed Professor
Chair, Department of Radiation Oncology
“Linde was remarkably positive, and she was incredibly strong. She went through so much, too. She had extensive surgery, followed by chemotherapy and radiation. All of that requires different doctors and care teams with different types of training. At Wilmot, we are fortunate to have the right experts in one place. Because of extraordinary philanthropy, we can continue to pursue answers to the questions this disease raises, and we can help more people because of it.”
Shawn D. Newlands, MD
Chair, Department of Otolaryngology
“It’s very difficult for one person to know all about every cancer. At Wilmot though, we have specialists who can address all aspects of a particular disease—including a disease like Linde’s that is rare and devastating, and among the most challenging cancers to address. Having the resources to recruit and retain world-class cancer researchers and clinicians is of vital importance. As the region’s leader in cancer treatment, your support helps us continue to offer patients like Linde ongoing access to cutting-edge clinical trials and novel treatments. Your support also helps us make the case for being a National Cancer Institute-designated cancer center. This high honor is based on rigorous standards of research scope, state-of-the-art-education, cancer prevention, and exemplary patient care.”
Jonathan Friedberg, MD, MMSc
Director, Wilmot Cancer Institute
“Linde was an amazing person who fought her cancer with tremendous courage and grace, and she inspired those of us fortunate enough to work with her. The Klein family’s support is very generous and will ultimately benefit underserved cancer patients. Head and neck cancers are relatively rare, and they do not typically receive a lot of traditional research funding. We are incredibly grateful to the Kleins and we will always keep Linde in our fond memories.”
Yuhchyau Chen, MD, PhD
Richard T. Bell Endowed Professor
Chair, Department of Radiation Oncology
“Linde was remarkably positive, and she was incredibly strong. She went through so much, too. She had extensive surgery, followed by chemotherapy and radiation. All of that requires different doctors and care teams with different types of training. At Wilmot, we are fortunate to have the right experts in one place. Because of extraordinary philanthropy, we can continue to pursue answers to the questions this disease raises, and we can help more people because of it.”
Shawn D. Newlands, MD
Chair, Department of Otolaryngology
Faces of Wilmot
Why Wilmot
“The Wilmot team develops an understanding of what the patient wants. Linde went home every day until the end. It was reassuring to us to have world-class experts and care just a few miles down the road. If something was urgent, we didn’t have to hop in a plane. We drove just a few miles to Wilmot.
My hope is that we can find the resources needed to get to the answers that will help people like Linde. There’s no place in the region like Wilmot. We must take advantage of the opportunity to support the work being done there.”
David Klein
“The Wilmot team develops an understanding of what the patient wants. Linde went home every day until the end. It was reassuring to us to have world-class experts and care just a few miles down the road. If something was urgent, we didn’t have to hop in a plane. We drove just a few miles to Wilmot.
My hope is that we can find the resources needed to get to the answers that will help people like Linde. There’s no place in the region like Wilmot. We must take advantage of the opportunity to support the work being done there.”
David Klein
